Discover investment opportunities in Biotechnology Stocks List using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotechnology Stocks List using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotechnology Stocks List using our Smart AI Filter.
10 stocks found for "Biotechnology Stocks List"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.22 | ±27.3% | 15.0 | 2.83% | |||
0.70 | ±46.8% | 1.5 | 0.00% | |||
0.36 | ±26.9% | 24.5 | 0.00% | |||
1.06 | ±44.4% | -272.1 | 0.00% | |||
0.60 | ±39.2% | 20.8 | 0.00% | |||
0.44 | ±32.3% | 11.1 | 0.00% | |||
0.45 | ±25.0% | 14.4 | 3.19% | |||
0.30 | ±26.0% | 12.1 | 0.66% | |||
0.34 | ±25.2% | 8.0 | 0.00% | |||
0.63 | ±35.0% | 27.1 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What makes biotechnology stocks like BIIB and GILD of interest to growth investors?
A: Biotechnology stocks such as BIIB and GILD often appeal to growth investors due to their potential for innovative drug development and treatment breakthroughs. These companies can experience significant revenue growth upon successful drug approval, although outcomes are not guaranteed.
Q: How do biotechnology companies like AMGN and VRTX typically perform during economic downturns?
A: Biotechnology companies like AMGN and VRTX might show resilience during economic downturns because healthcare demand generally remains stable. However, their performance can still depend on regulatory environments and drug pipeline success.
Q: What are the common risks associated with investing in biotech stocks such as MRNA and CRSP?
A: Investing in biotech stocks like MRNA and CRSP carries risks such as clinical trial failures, regulatory hurdles, and high R&D costs. These factors can lead to stock volatility and impact investor sentiment.
Q: Can biotechnology stocks like REGN and SGEN provide potential income for investors?
A: Typically, biotechnology stocks like REGN and SGEN focus on reinvesting earnings into research and development rather than providing high dividends. Therefore, they might not be ideal for investors seeking regular income.
Q: Why might an investor consider investing in ILMN's genomic sequencing technology?
A: Investors interested in ILMN's genomic sequencing could be drawn to its market leadership and potential for growth as personalized medicine and genetic research expand. However, competition and technological advancements in the sector could affect future prospects.
Q: How do biotechnology stocks like NVAX and MRNA impact public health initiatives?
A: Biotechnology companies such as NVAX and MRNA can significantly influence public health by developing vaccines and therapies for emerging health threats, though their financial success hinges on product effectiveness and market adoption.
Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors a better bang for their buck right now?
Read more